Anti-COVID-19 Biomedicines - A Layout Proposal for Production, Storage and Transportation
Shibabrata Pattanayak1, *
Identifiers and Pagination:Year: 2021
First Page: 166
Last Page: 188
Publisher ID: TOCOVIDJ-1-166
Article History:Received Date: 30/3/2021
Revision Received Date: 21/6/2021
Acceptance Date: 22/6/2021
Electronic publication date: 24/11/2021
Collection year: 2021
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Modulation of non-specific immunity and other related activities of succulent parts of effective medicinal plants can prevent viral infections like COVID-19 through their dietary intake.
The succulent parts of the medicinal plants with immunomodulation, anti-oxidation, anti-viral, anti-inflammatory, etc. power can be used orally in the capsular form to prevent as well as to reduce the severity of symptoms of COVID-19.
A proposal is displayed with a detailed description of related steps like the selection of medicinal plant parts consulting related reports, collection of biomedicines, validation of efficacy, dosing, encapsulation, storage, and transportation, etc.
The succulent bio-medicines against COVID-19 can be developed and marketed following only some adoptive research.
Succulent bio-medicines can be prepared and marketed for the prevention and cure of different infectious and non-infectious diseases.